Switch to
View more

SMS Pharmaceuticals Ltd

SMSPHARMA
Health CarePharmaceuticals
SmallcapWith a market cap of ₹731 cr, stock is ranked 1,170
Moderate RiskStock is 2.51x as volatile as Nifty
84.302.10 (-2.43%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹731 cr, stock is ranked 1,170
Moderate RiskStock is 2.51x as volatile as Nifty

Key MetricsEdit

PE RatioPE Ratio
11.75
PB RatioPB Ratio
1.56
Dividend YieldDiv. Yield
0.35%
Sector PESector PE
34.43
Sector PBSector PB
4.21
Sector Div YldSctr Div Yld
0.93%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

SMS Pharmaceuticals Limited is engaged in manufacturing and sale of bulk drugs and active pharmaceutical ingredients (APIs), and their intermediates.

Investor PresentationView older 

Aug 13, 2022

PDF
View Older Presentations

Financial TrendFinancial statements 

2019202020212022468.31417.06566.62525.0740.0431.5762.5162.22
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Decreased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has decreased by 3.12%

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

General updates 
Announced OnSep 13, 2022

SMS Pharmaceuticals Limited has informed the Exchange about Revised Auditor's Limited Review Report for Consolidated Financial Results for the Quarter ended 30th June 2022 | Download

SMS Pharmaceuticals Limited has informed the Exchange about Revised Auditor's Limited Review Report for Consolidated Financial Results for the Quarter ended 30th June 2022 | Download

Newspaper Advertisements 
Announced OnSep 8, 2022

SMS Pharmaceuticals Limited has informed the Exchange about Newspaper Advertisements dispatch of the Notice of the 34th AGM | Download

SMS Pharmaceuticals Limited has informed the Exchange about Newspaper Advertisements dispatch of the Notice of the 34th AGM | Download

Cash Dividend 
Ex. DateSep 22, 2022

Final • Div/Share: ₹ 0.3

See all events